Shanghai Dongfang Huayin Law Firm
Regarding Zhejiang Zoli Pharmaceutical Co., Ltd.
Legal Opinion on the Price Adjustment for the 2024 Restricted Stock Incentive Plan
To: Zhejiang Zoli Pharmaceutical Co., Ltd.
Shanghai Dongfang Huayin Law Firm (hereinafter referred to as "this Firm") has been engaged by Zhejiang Zoli Pharmaceutical Co., Ltd. (hereinafter referred to as "Zoli" or "the Company") to provide a legal opinion on the price adjustment for the 2024 restricted stock incentive plan (hereinafter referred to as "the Plan").
This legal opinion is based on the following facts and documents: